CAMBRIDGE, MA--(Marketwire - May 4, 2009) - On May 14, the MIT Enterprise Forum of
Cambridge will feature a panel discussion on the advancement and future of
tissue engineering, also known as regenerative medicine. With recent
advances in the fields of biochemistry, cell and molecular biology, and
genetics, tissue engineering has progressed rapidly and has the potential
to deliver dramatic improvements in medical care for hundreds of thousands
of patients.
Dr. Joseph P. Vacanti, a John Homans professor of surgery at Harvard
Medical School and chief of the Department of Pediatric Surgery at
Massachusetts General Hospital (MGH), will give the keynote address.
Following Vacanti's presentation, a team of panelists will discuss the
potential of tissue engineering, highlighting its unique challenges and
successes and probing the issues behind translating the science
successfully into business.
Keynote speaker:
Outside his work with the Harvard Medical School and the Department of
Pediatric Surgery at MGH, Dr. Joseph P. Vacanti is also surgeon-in-chief at
the MassGeneral Hospital for Children, co-director of the Center for
Regenerative Medicine, director of the Laboratory for Tissue Engineering
and Organ Fabrication, and chief of Pediatric Transplantation at MGH.
Vacanti received a B.S. from Creighton University, an M.D. from the
University of Nebraska's College of Medicine and an M.S. from Harvard
Medical School. He has been working in the field of tissue engineering
since its beginnings in the early 1980s.
Panelists:
Damien Bates is chief medical officer at Organogenesis, Inc., a leading
regenerative medicine company. Prior to joining Organogenesis, Bates served
as global medical director for Baxter BioSurgery. He holds an M.D. from the
University of Sydney and a Ph.D. in developmental biology from the
University of Melbourne.
Sudha Kadiyala is the senior director for business development and
strategic planning at Advanced Technologies and Regenerative Medicine LLC,
a subsidiary of Johnson & Johnson. Kadiyala has served in multiple roles at
other Johnson & Johnson subsidiaries, including director of cartilage and
soft tissue technologies and director of bone and spinal biologics.
Kadiyala has a Ph.D. in biomedical engineering from the Johns Hopkins
University School of Medicine, a Master's degree from the Thayer School of
Engineering at Dartmouth College and a Bachelor's degree from the Indian
Institute of Technology.
Michael J. Lysaght is the director of the Center for Biological Engineering
at Brown University. Before joining Brown in 1994, Lysaght held positions
at Amicon Corp., the Max Planck Institute for Biophysics in Frankfurt,
Germany, University Hospital of Munich, Baxter International and
CytoTherapeutics. Lysaght received an A.B. from Georgetown University, a
B.S. and M.S. in Chemical Engineering from MIT, and a Ph.D. in Biochemical
Engineering from the University of New South Wales.
Gary Arlen Smith, Esquire, is vice president and general counsel at
Tengion, a clinical-stage biotechnology company. Prior to joining Tengion,
Smith served as VP and general counsel for Enzon Pharmaceuticals, and
earlier was in private law practice, specializing in the life sciences
industry. He is a member of the Health and Science Desk Advisory Committee
of public broadcasting station WHYY. Smith earned a B.A. in chemistry from
Franklin and Marshall College and a law degree from Temple University
Beasley School of Law.
When: Thursday, May 14, 2009
5:30pm: Networking
6:15-8:00pm: Program
8:00-9:00pm: Networking Reception
Where: Stata Center (Bldg. 32), Kirsch Auditorium, 32 Vassar St.,
Cambridge, MA
Program organizers: Richard Smith, Edwards Angell Palmer & Dodge LLP,
John L. Brooks III, Healthcare Capital Consulting, Pearl Freier,
Cambridge BioPartners, Adriana Jenkins, William Whelan, Mintz Levin
Registration and information: http://www.mitforumcambridge.org/may.html
Pricing: Forum members: $20, Non-members: $30, MIT Staff with ID: $20.
Students from all universities are free with college ID. Pre-registration
is encouraged.
Contact Information: MIT ENTERPRISE FORUM OF CAMBRIDGE CONTACT:
Regina Smith
MIT Enterprise Forum of Cambridge
617-253-3937
PRESS CONTACT:
Brad Baker (for MIT Enterprise Forum)
CHEN PR, Inc.
781-672-3118